Ongoing

CRC Projects Round 17 - Novel precision medicine for FacioScapuloHumoral Muscular Dystrophy (FSHD)

Funding
$850,000
Region
Australia

Overview

This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.

Eligibility Requirements

Project involves collaborative partnerships between industry, research organizations, and universities. Participants must be part of an approved CRC Projects consortium.

Who Can Apply

Nonprofit

Relevant Industries

HealthBiotechnology

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page
Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants